Volume 25, Number 12—December 2019
Influenza A(H1N1)pdm09 Virus Infection in a Captive Giant Panda, Hong Kong
We report influenza A(H1N1)pdm09 virus infection in a captive giant panda in Hong Kong. The viral load peaked on day 1 and became undetectable on day 5, and an antibody response developed. Genome analysis showed 99.3%–99.9% nucleotide identity between the virus and influenza A(H1N1)pdm09 virus circulating in Hong Kong.
Since 2009, influenza A(H1N1)pdm09 virus (pH1N1) has been circulating seasonally worldwide and causing substantial illness, hospitalization, and death in humans every year. The virus has also caused infection in mammals and birds in addition to humans (1–3).
The giant panda (Ailuropoda melanoleuca) is considered a National Treasure of China with the highest legal protection and dedicated recovery programs. Any emerging infection in giant pandas is of utmost importance because they may not have adequate immunity against the pathogen, implying that such infection may rapidly spread to other giant pandas, leading to large outbreaks and fatalities (4). In this article, we describe a case of pH1N1 infection in a captive giant panda in an oceanarium in Hong Kong, China.
Ocean Park Hong Kong is a financially independent not-for-profit zoological park, oceanarium, and amusement park housing >5,000 marine and terrestrial animals of >500 species. There are 2 buildings for giant pandas in the park; 1 houses a 32-year-old male giant panda and the other a breeding pair.
On November 14, 2018, the 13-year-old male panda of the breeding pair was lethargic and had low appetite. Examination showed yellowish-brown mucoid nasal discharge, tachypnea (respiratory rate >60 breaths/min), and abdominal breathing. On day 2, his condition worsened, and he showed little appetite, persistent nasal discharge, and cough. Attempts at rectal temperature measurement and blood collection were unsuccessful in the first 2 days. We initiated treatment with ciprofloxacin, carprofen, bromhexine, and β-glucan and fogged his living quarters twice daily with F10 antiseptic solution (1:250 dilution) containing benzalkonium chloride and polyhexanide. Clinical surveillance performed on staff members of the park at the time when the giant panda was ill revealed that none of the animal caretakers had influenza-like illness around that time. Additional measures included placing rat traps to test resident rodents for influenza and increased biosecurity to limit contact between the breeding pair and between the staff and giant pandas at both panda facilities.
On day 3, the panda’s conditions and appetite improved. Nasal discharge was unchanged, but he only coughed occasionally. Rectal temperature was normal. Blood examination revealed leukocytosis with marked neutrophilia and lymphopenia, hypoferremia, and increased fibrinogen and globulins. He gradually improved in the next 5 days and has remained asymptomatic for 9 months after the onset of illness.
On day 1 of his illness, we collected nasal swab specimens for virologic studies; we collected additional nasal samples on days 2, 3, and 5 for viral load measurement. We took serial serum samples before and after the illness for serologic studies. Veterinary surgeons performed all sample collection.
We performed rapid antigen detection using BinaxNOW Influenza A & B Card (Alere, https://www.alere.com) and determined viral loads by quantitative real-time reverse transcription PCR (RT-PCR) targeting the M gene (5). We performed cell culture using MDCK cells inoculated with the first nasal swab sample; we examined it for cytopathic effect at 72 h. We performed serologic analyses using hemagglutination inhibition (HI) and microneutralization (MN) assays (6,7). We determined the complete genome sequencing of the culture isolate by Illumina HiSeq1500 (https://www.illumina.com) as described previously (8,9). We deposited the genome sequence in the GISAID database (http://platform.gisaid.org; accession no. EPI1493152 and nos. EPI1493160–6).
Rapid antigen detection on the nasal swab specimen collected on day 1 was positive for influenza A virus. The viral load (± SD) in the nasal swabs on day 1 of the illness was 5.84 ± 0.07 log10 copies/mL; on day 2, 5.81 ± 0.05 log10 copies/mL; and on day 3, 2.83 ± 0.16 log10 copies/mL. On day 5, viral loads became undetectable (Figure 1). MDCK cells inoculated with the nasal sample showed cytopathic effect on day 3 of incubation with cell rounding, progressive degeneration, and detachment. Serologically, HI and MN antibodies against pH1N1 were undetectable >40 days before the onset of the illness and on days 1 and 4 of the illness, but high titers (HI, 1:320; MN, 1:160) were detected in the second and the fourth week after the onset of the illness (Figure 1). The other 2 giant pandas did not develop any clinical signs, and their nasal swab specimens remained negative by RT-PCR.
Whole-genome sequence analysis showed that the influenza virus we isolated from the giant panda (A/giant panda/Hong Kong/MISO20/2018) was closely related to other pH1N1 viruses circulating among humans in 2018, sharing 99.3%–99.9% nucleotide identities (Table). Phylogenetic analyses based on the hemagglutinin (HA) and neuraminidase (NA) gene sequences showed that A/giant panda/Hong Kong/MISO20/2018 was most closely related to the human pH1N1 strain A/Hong Kong/2272/2018, which was circulating in Hong Kong at the time at which the giant panda acquired the infection (Figure 2; Appendix Figure). There were only 2 bases difference between the HA genes and 4 bases difference between the NA genes of A/giant panda/Hong Kong/MISO20/2018 and A/Hong Kong/2272/2018, but 60 bases difference between the HA genes and 45 bases difference between the NA genes of A/giant panda/Hong Kong/MISO20/2018 and A/giant panda/01/Ya’an/2009, a pH1N1 virus previously isolated in giant panda in China (1). Phylogenetic analyses based on the other gene segments displayed similar topologies (Appendix Figure). Detailed annotation of the genome sequence of the giant panda isolate revealed features essential for transmission and replication of pH1N1 in other mammalian species. For example, A/giant panda/Hong Kong/MISO20/2018 also possessed glutamine at position 226 (H3 numbering) in HA and alanine at position 271 in polymerase protein 2 (1).
We documented a case of influenza infection caused by pH1N1 virus in a captive giant panda in Hong Kong. The viral load was >6 × 105 copies/mL during the first 2 days of the illness and decreased to an undetectable level on day 5. The decrease in viral load was coupled with development of antibody response. Complete genome sequencing and phylogenetic analysis showed that the pH1N1 virus from the giant panda differed from the influenza virus circulating in Hong Kong at that time by only 2–24 bases. In 2014, pH1N1 infection was reported in giant pandas at the Conservation and Research Center for the Giant Panda in Sichuan (1). That pH1N1 virus, A/giant panda/01/Ya’an/2009, was also closely related to the pH1N1 strains circulating in humans during 2009 (1).
These findings show that influenza A virus infection in this giant panda was not an isolated case and that these infections have happened not only in mainland China. Our findings indicate that the influenza virus in giant pandas was most likely directly or indirectly from humans with seasonal influenza. Of interest, respiratory infection in a sloth bear due to pH1N1 has also been observed in a zoo in the United States in 2014, indicating that pH1N1 can probably infect a variety of bears (2).
In animal species with no preexisting immunity against an infectious agent, a new intrusion of the pathogen may result in high fatalities. Transmission of a new strain of influenza from birds and poultry to humans has resulted in many epidemics (10–15). Because the inactivated vaccine against pH1N1 has been widely used in humans and is effective in mice, pigs, and ferrets, it might be worthwhile to test its immunogenicity in giant pandas. Moreover, caretakers working at these parks who are infected with influenza, even with mild illness or in recovery, should not work near the animals.
Dr. Martelli, a zoological veterinarian, is currently Director of Veterinary Services at Hong Kong Ocean Park.
We thank the members of the Centre for Genomic Sciences, The University of Hong Kong, for their technical support. This work is partly supported by funding from Ocean Park Hong Kong and the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the Ministry of Education of China.
- Li D, Zhu L, Cui H, Ling S, Fan S, Yu Z, et al. Influenza A(H1N1)pdm09 virus infection in giant pandas, China. Emerg Infect Dis. 2014;20:480–3. DOIPubMedGoogle Scholar
- Boedeker NC, Nelson MI, Killian ML, Torchetti MK, Barthel T, Murray S. Pandemic (H1N1) 2009 influenza A virus infection associated with respiratory signs in sloth bears (Melursus ursinus). Zoonoses Public Health. 2017;64:566–71. DOIPubMedGoogle Scholar
- Keenliside J. Pandemic influenza A H1N1 in swine and other animals. In: Richt JA, Webby RJ, editors. Swine influenza. Current topics in microbiology and immunology, vol 370. Heidelberg: Springer; 2012..
- Feng N, Yu Y, Wang T, Wilker P, Wang J, Li Y, et al. Fatal canine distemper virus infection of giant pandas in China. Sci Rep. 2016;6:27518. DOIPubMedGoogle Scholar
- To KK, Chan KH, Li IW, Tsang TY, Tse H, Chan JF, et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol. 2010;82:1–7. DOIPubMedGoogle Scholar
- Chan KH, To KK, Hung IF, Zhang AJ, Chan JF, Cheng VC, et al. Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza. Clin Vaccine Immunol. 2011;18:867–73. DOIPubMedGoogle Scholar
- Hung IF, To KK, Lee CK, Lin CK, Chan JF, Tse H, et al. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis. 2010;51:274–9. DOIPubMedGoogle Scholar
- Guan TP, Teng JLL, Yeong KY, You ZQ, Liu H, Wong SSY, et al. Metagenomic analysis of Sichuan takin fecal sample viromes reveals novel enterovirus and astrovirus. Virology. 2018;521:77–91. DOIPubMedGoogle Scholar
- Woo PC, Lau SK, Teng JL, Tsang AK, Joseph M, Wong EY, et al. Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses. Virology. 2014;471-473:117–25. DOIPubMedGoogle Scholar
- Refaey S, Azziz-Baumgartner E, Amin MM, Fahim M, Roguski K, Elaziz HA, et al. Increased number of human cases of influenza virus A(H5N1) infection, Egypt, 2014–15. Emerg Infect Dis. 2015;21:2171–3. DOIPubMedGoogle Scholar
- Wei SH, Yang JR, Wu HS, Chang MC, Lin JS, Lin CY, et al. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir Med. 2013;1:771–8. DOIPubMedGoogle Scholar
- Goneau LW, Mehta K, Wong J, L’Huillier AG, Gubbay JB. Zoonotic influenza and human health—part 1: virology and epidemiology of zoonotic influenzas. Curr Infect Dis Rep. 2018;20:37. DOIPubMedGoogle Scholar
- Ke C, Lu J, Wu J, Guan D, Zou L, Song T, et al. Circulation of reassortant influenza A(H7N9) viruses in poultry and humans, Guangdong Province, China, 2013. Emerg Infect Dis. 2014;20:2034–40. DOIPubMedGoogle Scholar
- Zhang T, Bi Y, Tian H, Li X, Liu D, Wu Y, et al. Human infection with influenza virus A(H10N8) from live poultry markets, China, 2014. Emerg Infect Dis. 2014;20:2076–9. DOIPubMedGoogle Scholar
- Nga VT, Ngoc TU, Minh LB, Ngoc VTN, Pham VH, Nghia LL, et al. Zoonotic diseases from birds to humans in Vietnam: possible diseases and their associated risk factors. Eur J Clin Microbiol Infect Dis. 2019;38:1047–58. DOIPubMedGoogle Scholar
TableCite This Article
Original Publication Date: November 12, 2019
1These authors contributed equally to this article.
Table of Contents – Volume 25, Number 12—December 2019
|EID Search Options|
|Advanced Article Search – Search articles by author and/or keyword.|
|Articles by Country Search – Search articles by the topic country.|
|Article Type Search – Search articles by article type and issue.|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Patrick C.Y. Woo or Susanna K.P. Lau, Queen Mary Hospital, Department of Microbiology, 19/F, Block T, 102 Pokfulam Rd, Hong Kong, China; or